Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reflects strong financial metrics with record investment income and strategic growth in reinsurance and specialty insurance. Despite some areas of decline, such as casualty premiums, the company is optimizing its portfolio, expecting growth in several lines, and maintaining attractive risk-adjusted returns. The Q&A indicates confidence in reserve management and strategic divestments, with plans for capital repatriation. Share repurchases and a favorable investment outlook further support a positive sentiment. However, cautious guidance and a competitive market temper expectations, suggesting moderate stock price appreciation.
Group Gross Written Premium $4.4 billion, down 1% year-over-year, largely reflecting targeted re-underwriting in Insurance and careful portfolio mix management in Reinsurance.
Combined Ratio 103.4% for the quarter. Excluding prior year development and net cat losses, the attritional combined ratio was 89.6%, demonstrating the strength of the underlying book.
Operating Income $316 million compared with $630 million last year, the difference almost entirely attributable to the reserve adjustment.
Reinsurance Gross Written Premium $3.2 billion, down 2% year-over-year, reflecting disciplined cycle management.
Reinsurance Combined Ratio 87%, improving year-over-year, driven by lower cat losses and favorable prior year development.
Global Specialties Business Gross Written Premium Almost $500 million, with over $100 million of underwriting income in the quarter.
Insurance Gross Premiums Written $1.1 billion, increased 2.7% in constant dollars, driven by strong growth in Other Specialty and Accident & Health, offset by aggressive actions in U.S. casualty lines.
Net Investment Income $540 million for the quarter, driven by higher assets under management and strong alternative asset returns.
Book Value Per Share $366.22, an improvement of 15.2% from year-end 2024, adjusted for dividends of $6 per share year-to-date.
Exit from global retail insurance: Everest is exiting the global retail insurance market, which includes U.S., U.K., European, and Asia Pacific commercial retail insurance businesses. This move is expected to release significant capital over time and streamline operations.
Focus on wholesale and specialty insurance: The company is reorganizing its insurance operations to focus on global wholesale and specialty insurance capabilities, which historically outperformed retail business by approximately 10 combined ratio points.
Adverse development cover for North America insurance: Everest established a $1.2 billion adverse development cover for North America insurance reserves for accident years 2024 and prior, ensuring legacy issues do not overshadow current performance.
Reserve strengthening: The company strengthened its U.S. casualty reserves by $478 million on a net basis, addressing prior poor underwriting decisions and ensuring a more conservative approach to loss picks.
Strategic shift to core businesses: Everest is focusing on its core Reinsurance and Wholesale & Specialty insurance businesses, which are performing well and have strong growth potential.
Capital flexibility and shareholder returns: The company is positioning itself for greater capital flexibility to invest in growth opportunities and return capital to shareholders.
Exit from Global Retail Insurance: The company is exiting global retail insurance due to the high ongoing investments and capital requirements, which are deemed better allocated elsewhere. This decision could lead to transitional challenges and potential revenue loss from the $2 billion gross written premiums associated with this business.
Adverse Development Cover (ADC) Implementation: The establishment of an ADC for North America insurance reserves involves a $1.2 billion gross limit and a co-participation of $200 million. This will result in a pretax nonoperating charge of $250 million to $350 million over 2025 and 2026, and a reduction in net investment income by approximately $60 million annually.
Reserve Strengthening: The company strengthened its U.S. casualty reserves by $478 million, driven by large loss activity and higher frequency in certain liability lines. This reflects ongoing challenges in managing U.S. casualty risks and could impact profitability.
Social Inflation and Elevated Risk Environment: The U.S. casualty portfolio faces challenges due to social inflation and an elevated risk environment, particularly in excess casualty and management liability lines. This has necessitated more conservative loss assumptions and reserve strengthening.
Portfolio Reorganization: The reorganization to focus on wholesale and specialty insurance may lead to operational disruptions and transitional risks as the company exits underperforming accounts and shifts its strategic focus.
Reduced Gross Written Premiums: Group gross written premiums decreased by 1%, and reinsurance premiums decreased by 2%, reflecting targeted re-underwriting and portfolio adjustments. This could indicate challenges in maintaining premium growth while optimizing the portfolio.
Net Investment Income Impact: Net investment income is expected to decrease by $60 million annually due to the ADC transaction, potentially impacting overall financial performance.
Casualty Reserving Issues: The company has faced persistent issues with U.S. casualty reserving, requiring significant reserve strengthening and conservative loss picks, which could continue to affect financial stability.
Market conditions in Reinsurance: Market conditions in the Reinsurance business, particularly in cat-exposed lines, are expected to remain favorable through the January 1, 2026, renewal. While market capacity is increasing, Everest is a preferred partner, and the company sees no barriers to continued attractive capital deployment in this market. However, the company will cut back on deals that do not offer attractive and appropriate returns.
Global Specialties business growth: The company is investing in its Global Specialties business and expects it to deliver top and bottom-line growth in the coming quarters and years.
Insurance portfolio profitability: The company is maintaining pricing momentum, improving risk selection, and exiting underperforming accounts, which positions the go-forward Insurance portfolio for increased profitability.
Focus on Wholesale and Specialty Insurance: The company is reorganizing its insurance operation to focus on global wholesale and specialty insurance capabilities. Historically, these businesses outperformed the retail business by approximately 10 combined ratio points. The long-term profitability and growth outlooks for these market segments are excellent.
Capital deployment and flexibility: The company is moving to a position of significant excess capital to deploy, with a focus on disciplined execution and maintaining a strong balance sheet.
Adverse Development Cover (ADC): The company entered into an adverse development cover providing $1.2 billion of gross limit for North American insurance subject reserves for accident years 2024 and prior. This is expected to lower net investment income by approximately $60 million per year over the next several years.
Share repurchases: The company expects to resume meaningful share repurchases going forward.
Dividends: Book value per share ended the quarter at $366.22, an improvement of 15.2% from year-end 2024, when adjusted for dividends of $6 per share year-to-date.
Share Repurchase: We did not repurchase any shares in the quarter. However, we continue to view share repurchases as an attractive opportunity to deploy capital, and we expect to resume meaningful share repurchases going forward.
The earnings call reflects strong financial metrics with record investment income and strategic growth in reinsurance and specialty insurance. Despite some areas of decline, such as casualty premiums, the company is optimizing its portfolio, expecting growth in several lines, and maintaining attractive risk-adjusted returns. The Q&A indicates confidence in reserve management and strategic divestments, with plans for capital repatriation. Share repurchases and a favorable investment outlook further support a positive sentiment. However, cautious guidance and a competitive market temper expectations, suggesting moderate stock price appreciation.
The earnings call summary reveals mixed signals. The financial performance and product development updates are generally positive, with strong international growth and share repurchases. However, the combined ratio indicates ongoing pressure from losses, and there are concerns about expense ratios and the impact of tariffs. The Q&A section did not provide clear answers on critical issues, such as tariff impacts and expense improvements. The lack of clarity and mixed results suggest a neutral sentiment, with no strong catalysts for significant stock movement.
The earnings call presents mixed signals. Financial performance shows increased losses and flat premium growth, but net investment income is strong. The Q&A reveals potential growth in Florida and specialty lines, but competitive pressures and management's reluctance to provide guidance raise concerns. Share repurchases are positive, but the attritional loss ratios and catastrophe impacts are negative. Overall, the sentiment is neutral, with no strong indicators for significant stock price movement.
The earnings call summary shows strong financial performance with increased operating earnings per share, improved combined ratio, and robust cash flow. Share repurchase and dividends indicate shareholder confidence. However, concerns about catastrophe losses and cautiousness in casualty lines were noted. The Q&A revealed management's confidence in achieving targets and firming pricing, despite some vague responses. Overall, the positive financial metrics and strategic shareholder returns outweigh the risks, suggesting a positive stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.